Back to Search Start Over

Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer

Authors :
Guillermo Villacampa
Vicente Peg
Ángela Quintana
M. Vazquez
Mercè Martí
Juan Blanco-Heredia
Aleix Prat
Carla dos Anjos
Patricia Galván
Peter Schmid
Eva Muñoz-Couselo
Laia Paré
Leticia De Mattos-Arruda
Rodrigo Dientsmann
Jose Perez-Garcia
Giuseppe Curigliano
Teresa Moliné
Javier Cortes
Barcelona Supercomputing Center
Source :
European Journal of Cancer, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname, UPCommons. Portal del coneixement obert de la UPC, Universitat Politècnica de Catalunya (UPC)
Publication Year :
2021
Publisher :
Elsevier BV, 2021.

Abstract

Triple-negative breast cancer (TNBC) is a subtype of breast cancer with unmet medical needs. Several studies have proved that high levels of tumor infiltrating lymphocytes (TILs) at diagnosis of TNBC confer better prognosis and patients respond better to specific chemotherapies. Nonetheless, current evidence suggests that only 15% of TNBC patients have very high levels of TILs, and another 15% lacks TILs. One possible reason to explain why patients have low TILs at diagnosis is that lymphocytes might be deactivated by an immune checkpoint in local lymph nodes, provoking their retention in there as they are unresponsive to other immune stimuli. We have identified 15 high TILs (≥50%) and 20 low TILs (≤5%) TNBC patients with localised tumour (T1c-T2N0M0) and compared the protein expression of five immune checkpoints in lymph nodes. We have also performed a customised 50-immune gene NanoString expression panel, the NanoString 360 Breast Cancer panel, and whole exome sequencing for mutation and neoantigen load analyses. In low TILs, we observed higher expression of CTLA-4 in local lymph nodes, which could explain why lymphocytes get retained in there and do not migrate to tumour. These patients have also higher neoantigen load and higher expression of B7.H3 and B7.H4 in the tumour. In high TILs, we observed more PD-L1+ tumour cells and more expanded humoral response. These results could provide a strategy to revert low tumour immune infiltration at diagnosis of TNBC, improving their prognosis. This project was supported by a grant from INTHEOS Foundation, thanks to the donation received from Pompadour, and from FERO Foundation. Peer Reviewed "Article signat per 18 autors/es: Ángela Quintana, Vicente Peg, Aleix Prat, Teresa Moliné, Guillermo Villacampa, Laia Paré, Patricia Galván, Rodrigo Dientsmann, Peter Schmid, Giuseppe Curigliano, Eva Muñoz-Couselo, José Perez-Garcia, Merce Marti, Juan Blanco-Heredia, Carla dos Anjos, Miguel Vazquez, Leticia De Mattos-Arruda, Javier Cortés"

Details

ISSN :
09598049
Volume :
148
Database :
OpenAIRE
Journal :
European Journal of Cancer
Accession number :
edsair.doi.dedup.....072ce289166625648c2c8ef429e44f34